Close Menu

If a researcher takes a swab of your nose and finds a new species of bacteria, the discovery of which leads to the development of a new drug, do you deserve a cut of those profits, asks Carl Zimmer in The New York Times. More and more, bioethicists are asking questions about people's relationships with their microbiomes, Zimmer says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.